PRACA ORYGINALNA
DISEASE ACTIVITY, QUALITY OF LIFE AND INDIRECT COSTS OF REDUCED PRODUCTIVITY AT WORK, GENERATED BY PATIENTS WITH AS. A CASE OF POLAND
Więcej
Ukryj
Data nadesłania: 16-11-2015
Data ostatniej rewizji: 03-01-2016
Data akceptacji: 08-01-2016
Data publikacji online: 11-02-2016
Data publikacji: 15-02-2016
Reumatologia 2015;53(6):301-308
SŁOWA KLUCZOWE
DZIEDZINY
STRESZCZENIE
Objectives: The aim of the study was to investigate the association between activity of ankylosing spondylitis (AS) and decrease in quality of life as well as productivity loss of affected patients in a specified group of patients in the Polish setting.
Material and methods: An questionnaire survey was conducted using the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) to assess disease activity, as well as the Work Productivity and Activity Impairment Questionnaires to assess productivity loss; quality of life was presented as utility calculated using the EuroQol 5 questionnaire and also measured on a visual analogue scale (VAS). Indirect costs were assessed with the human capital approach implying gross domestic product per capita or gross value added per worker in Poland in 2014 and were expressed in Polish zlotys (PLN) as well as in euros. Correlation was presented using Spearman’s rank correlation coefficient.
Results: We performed our analysis based on 78 full questionnaires collected. A mean BASDAI score of 5.91 in the analysed group of patients was detected and mean utility of 0.5135 was observed. Average quality of life measured on the visual analogue scale was 46.55. Mean number of days off work was 45.26 days per year and mean on-the-job productivity loss was 49.29%. Average annual indirect costs per patient were €4241 (17 686 PLN) calculated using gross domestic product and €10 172 (42 417 PLN) estimated using gross value added. Total productivity loss was significantly correlated with disease activity (strong correlation of 0.6005) and utility (moderate correlation of –0.3698).
Conclusions: Ankylosing spondylitis causes a great decrease in quality of life as well as patients’ productivity loss associated with both absenteeism and presenteeism. The greater the disease activity is, the lower is the utility, the lower is the quality of life measured on the VAS, and the greater are the total annual indirect costs. Total indirect costs were negatively correlated with utility; although the association was moderate, it was significant.
REFERENCJE (17)
1.
Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007; 369: 1379-1390.
2.
Śliwczyński A, Raciborski F, Kłak A, et al. Prevalence of ankylosing spondylitis in Poland and costs generated by AS patients in the public healthcare system. Rheumatol Int 2015; 35: 1361-1367.
3.
BASDAI Bath Ankylosing Spondylitis Disease Activity Index.
http://basdai.com/ Last Access: October 2015.
5.
Mok CC, Kwok CL, Ho LY, et al. Life Expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. Arthritis Rheum 2011; 63: 1182-1189.
6.
Krol M, Brouwer W. How to estimate productivity costs in economic evaluations. PharmacoEconomics 2014; 32: 335-344.
7.
Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics 1993; 4: 353-365.
9.
Jankowska-Polańska B, Polański J. Metody oceny jakości życia w schorzeniach reumatycznych. Reumatologia 2014; 52: 69-76.
10.
Szende, Oppe, Devlin (ed.). EuroQol 5 Value Sets: Inventory, comparative review, and user guide. Springer Netherlands, 2007.
12.
Havik K, Mc Morrow K, Raciborski R. The production function methodology for calculating potential growth rates and output rates, European Commission, Directorate-General for Economic and Financial Affairs (2014).
http://ec.europa.eu/economy_fi....
13.
R Core Team (2015). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL
http://www.R-project.org/.
14.
Bebrysz M, Fedyna M, Rutkowski J, Hałdaś M. Indirect Costs of Immune-mediated Inflamatory diseases in Poland. CEESTAHC, 2014.
15.
Rafia R, Ara R, Packham J, et al. Healthcare costs and productivity losses directly attributable to ankylosing spondylitis. Clin Exp Rheumatol 2012; 30: 246-253.
16.
Boonen A, Brinkhuizen T, Landewé R, et al. Impact of ankylosing spondylitis on sick leave, presenteeism and unpaid productivity, and estimation of the societal cost. Ann Rheum Dis 2010; 69: 1123-1128.
17.
Survey on work, NASS data on File: RM 16094 (November 2009).
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.